ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies
Open accessThe DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Abstract
Ischaemic heart disease (IHD) remains the leading cause of death and disability worldwide. As a result, novel therapies are still needed to protect the heart from the detrimental effects of acute ischaemia-reperfusion injury, in order to improve clinical outcomes in IHD patients. In this regard, although a large number of novel cardioprotective therapies discovered in the research laboratory have been investigated in the clinical setting, only a few of these have been demonstrated to improve clinical outcomes. One potential reason for this lack of success may have been the failure to thoroughly assess the cardioprotective efficacy of these novel therapies in suitably designed preclinical experimental animal models. Therefore, the aim of this Position Paper by the European Society of Cardiology Working Group Cellular Biology of the Heart is to provide recommendations for improving the preclinical assessment of novel cardioprotective therapies discovered in the research laboratory, with the aim of increasing the likelihood of success in translating these new treatments into improved clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Power failure: why small sample size undermines the reliability of neuroscience
Button, K. S., Ioannidis, J. P. A., Mokrysz, C., Nosek, B. A., Flint, J., Robinson, E. S. J., & Munafò, M. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3475 · Cited by 7,641 · cited 1×
“underpowered.(18) It cannot be assumed that studies in the cardioprotection field would fare much better.”
BackgroundImproving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · CHANCE · doi:10.1080/09332480.2005.10722754 · Cited by 4,702
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
Piot, C., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., Elbelghiti, R., Cung, T. T., Bonnefoy, E., Angoulvant, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071142 · Cited by 1,339
Self-citationThe heart and cardiovascular system
Fozzard, H. A., Haber, E., Jennings, R. B., & Katz, A. (1986) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 1,330
Postconditioning the Human Heart
Staat, P., Rioufol, G., Piot, C., Cottin, Y., Cung, T. T., L’Huillier, I., Aupetit, J.-F., Bonnefoy, E., Finet, G., André-Fouët, X., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.558122 · Cited by 999
Self-citationBøtker, H. E., Kharbanda, R., Schmidt, M. R., Bøttcher, M., Kaltoft, A. K., Terkelsen, C. J., Munk, K., Andersen, N. H., Hansen, T. M., Trautner, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62001-8 · Cited by 989
Body size, energy metabolism and lifespan
Speakman, J. R. (2005) · Journal of Experimental Biology · doi:10.1242/jeb.01556 · Cited by 914 · cited 2×
“As a general rule, there is an inverse relationship between body weight and heart rate across animal species due to size-dependent differences in a metabolic demand.(86,87) Consequently, oxygen consumption and”
BackgroundRevised standards for statistical evidence
Johnson, V. E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313476110 · Cited by 808 · cited 1×
“not necessarily imply that reproducibility will occur at least 95% of the time.(16)”
BackgroundFerdinandy, P., Schulz, R., & Baxter, G. F. (2007) · Pharmacological Reviews · doi:10.1124/pr.107.06002 · Cited by 744 · cited 2×
“In thehypertensiveheartwith orwithoutLVhypertrophy, while cardioprotection by preconditioning is still present, reduction in MI size by ischaemic postconditioning appears to be lost.(97,105,106) Most of the preclinical studies, together with some small scale clinical”
BackgroundSelf-citationCardiovascular remodelling in coronary artery disease and heart failure
Heusch, G., Libby, P., Gersh, B., Yellon, D., Böhm, M., Lopaschuk, G., & Opie, L. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60107-0 · Cited by 734 · cited 3×
“However, reduced contractile function in the setting of myocardial I/R is difficult to interpret, as it may reflect adaptation to ischaemia as in hibernating myocardium,(80,81) reversible injury as in stunning,(63) irreversible injury from infarction, or remodelling post-MI.(1)”
BackgroundMethodInfluentialSelf-citationHausenloy, D. J., Mwamure, P. K., Venugopal, V., Harris, J., Barnard, M., Grundy, E., Ashley, E., Vichare, S., Di Salvo, C., Kolvekar, S., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61296-3 · Cited by 680
Self-citationPreclinical research: Make mouse studies work
Perrin, S. (2014) · Nature · doi:10.1038/507423a · Cited by 668 · cited 3×
“Therefore, the conclusions of these studies should be interpreted with caution.(24) When studying novel cardioprotective therapies in genetically modified animals, the choice of the littermate wild-type control over the original strain mouse is also critical as a small genetic variation often incorrectly considered as…”
BackgroundInfluentialRelaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms
Bassani, J. W., Bassani, R. A., & Bers, D. M. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020130 · Cited by 662
The role of neutrophils in myocardial ischemia–reperfusion injury
Jordan, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00187-x · Cited by 646 · cited 1×
“This model is most often used for perfusing hearts from small animals such as mice, rats, rabbits, and guinea pigs, but it can also be used for larger animal hearts from pig and even human hearts.(37,38) The ischaemic insult is induced regionally by coronary ligation (thereby mimicking a clinical AMI) or globally via…”
MethodSIRT1 Mediates Central Circadian Control in the SCN by a Mechanism that Decays with Aging
Chang, H.-C., & Guarente, L. (2013) · Cell · doi:10.1016/j.cell.2013.05.027 · Cited by 615
Ferdinandy, P., Hausenloy, D. J., Heusch, G., Baxter, G. F., & Schulz, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008300 · Cited by 562
Self-citationExenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
Lønborg, J., Vejlstrup, N., Kelbæk, H., Bøtker, H. E., Kim, W. Y., Mathiasen, A. B., Jørgensen, E., Helqvist, S., Saunamäki, K., Clemmensen, P., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr309 · Cited by 550
Cardioprotection: chances and challenges of its translation to the clinic
Heusch, G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60916-7 · Cited by 546 · cited 1×
“This subject has been extensively reviewed in our recently published ESC WG Cellular Biology of the Heart Position Papers(4,5) and elsewhere.(2,6)”
MethodSelf-citationRetrograde heart perfusion: The Langendorff technique of isolated heart perfusion
Bell, R. M., Mocanu, M. M., & Yellon, D. M. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.02.018 · Cited by 505 · cited 2×
“In the isolated heart, the use of an intraventricular balloon connected to a transducer/chart recorder will give useful functional parameters including heart rate and LV developed pressure.(35) Insertion of a catheter can capture realtime right or LV pressure–volume loops, and these can be used in vitro or in vivo to…”
MethodSelf-citationOvize, M., Baxter, G. F., Di Lisa, F., Ferdinandy, P., Garcia-Dorado, D., Hausenloy, D. J., Heusch, G., Vinten-Johansen, J., Yellon, D. M., & Schulz, R. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq129 · Cited by 502
Self-citationCircadian Rhythms and Metabolic Syndrome: From Experimental Genetics to Human Disease
Maury, E., Ramsey, K. M., & Bass, J. (2010) · Circulation Research · doi:10.1161/circresaha.109.208355 · Cited by 500 · cited 2×
“Co-morbidities such as diabetes can further disturb circadian rhythms as has been demonstrated in patients.(112,119)”
BackgroundSmall and large animal models in cardiac contraction research: advantages and disadvantages
Milani-Nejad, N., & Janssen, P. M. L. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.007 · Cited by 484 · cited 3×
“Small-sized animals, typically mice and rats, and to a lesser extent guinea pigs and rabbits, are extensively used in cardioprotection studies, mainly due to their lower cost, shorter gestation time, easier handling, and well-characterized native or manipulated genetic profile.84 This practice is facilitated by the av…”
BackgroundInfluentialThielmann, M., Kottenberg, E., Kleinbongard, P., Wendt, D., Gedik, N., Pasa, S., Price, V., Tsagakis, K., Neuhäuser, M., Peters, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61450-6 · Cited by 483
Self-citationCellular basis of abnormal calcium transients of failing human ventricular myocytes
Piacentino, V., Weber, C. R., Chen, X., Weisser-Thomas, J., Margulies, K. B., Bers, D. M., & Houser, S. R. (2003) · Circulation Research · doi:10.1161/01.res.0000062469.83985.9b · Cited by 477
Timmers, L., Henriques, J. P. S., de Kleijn, D. P. V., DeVries, J. H., Kemperman, H., Steendijk, P., Verlaan, C. W. J., Kerver, M., Piek, J. J., Doevendans, P. A., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.033 · Cited by 470
Handbook of Laboratory Animal Science: Animal Models, Volume II
(2002) · CRC Press eBooks · doi:10.1201/9781420040920 · Cited by 432
Myocardial Protection at a Crossroads: The Need for Translation Into Clinical Therapy
Bolli, R., Becker, L., Gross, G., Mentzer, R., Balshaw, D., & Lathrop, D. A. (2004) · Circulation Research · doi:10.1161/01.res.0000137171.97172.d7 · Cited by 428
Coronary Microembolization: From Bedside to Bench and Back to Bedside
Heusch, G., Kleinbongard, P., Böse, D., Levkau, B., Haude, M., Schulz, R., & Erbel, R. (2009) · Circulation · doi:10.1161/circulationaha.109.888784 · Cited by 419 · cited 1×
“drome simulating the microvascular obstruction and dysfunction, which occurs in these patients.(44) Repetitive intracoronary infusion of microparticles induces severe myocardial dysfunction and has been used as an experimental model of ischaemic heart failure.”
MethodSelf-citationAnimal Models of Cardiovascular Diseases
Zaragoza, C., Gomez-Guerrero, C., Martin-Ventura, J. L., Blanco-Colio, L., Lavin, B., Mallavia, B., Tarin, C., Mas, S., Ortiz, A., & Egido, J. (2011) · BioMed Research International · doi:10.1155/2011/497841 · Cited by 402 · cited 1×
“Although selective breeding for production purposes have distanced adult swine heart/body weight relationship from that present in humans, pigs are considered the better suited animals for cardioprotection studies,(92) because they share with humans similar coronary circulation anatomy and aortic histology, as well as…”
BackgroundIbanez, B., Macaya, C., Sánchez-Brunete, V., Pizarro, G., Fernández-Friera, L., Mateos, A., Fernández-Ortiz, A., García-Ruiz, J. M., García-Álvarez, A., Iñiguez, A., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003653 · Cited by 394
KOTTENBERG, E., THIELMANN, M., BERGMANN, L., HEINE, T., JAKOB, H., HEUSCH, G., & PETERS, J. (2012) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2011.02585.x · Cited by 363 · cited 1×
“1 Choice of anaesthetic Although volatile anaesthetics arecurrently the preferreddrug of choice to anaesthetize animals in preclinical experiments, their use in cardioprotective studies has been limited, due to their inherent cardioprotective properties.(19,67,68) Ex vivo, the use of sodium pentobarbitone remains the…”
BackgroundSelf-citationThe myocardial JAK/STAT pathway: From protection to failure
BOENGLER, K., HILFIKERKLEINER, D., DREXLER, H., HEUSCH, G., & SCHULZ, R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.002 · Cited by 362 · cited 1×
“Closed-chest models of AMI, in which occlusion is performed by intracoronary devices (most frequently by catheterization and inflation of an angioplasty balloon), can be performed in rodents and large animals.(42,43) These models have the advantage of not being associated with the surgical trauma and inflammation asso…”
MethodSelf-citationOerlemans, M. I. F. J., Liu, J., Arslan, F., Ouden, K., Middelaar, B. J., Doevendans, P. A., & Sluijter, J. P. G. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0270-8 · Cited by 328
Self-citationLoss of cardioprotection with ageing
Boengler, K., Schulz, R., & Heusch, G. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp033 · Cited by 328
Self-citationCalcium-mediated cell death during myocardial reperfusion
Garcia-Dorado, D., Ruiz-Meana, M., Inserte, J., Rodriguez-Sinovas, A., & Piper, H. M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs116 · Cited by 307
Self-citationSonne, D. P., Engstrøm, T., & Treiman, M. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2007.10.001 · Cited by 294 · cited 1×
“Similarly, exenatide was first shown to be cardioprotective during reperfusion in isolated rat hearts.(131) Importantly, this was subsequently confirmed in a pig model by an independent group,(132) before progressing to an appropriately designed study,(133) which demonstrated improved myocardial salvage in patients un…”
BackgroundA canine model of chronic heart failure produced by multiple sequential coronary microembolizations
Sabbah, H. N., Stein, P. D., Kono, T., Gheorghiade, M., Levine, T. B., Jafri, S., Hawkins, E. T., & Goldstein, S. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.260.4.h1379 · Cited by 282 · cited 1×
“Repetitive intracoronary infusion of microparticles induces severe myocardial dysfunction and has been used as an experimental model of ischaemic heart failure.(45) Intracoron-”
MethodZaugg, M., Lucchinetti, E., Spahn, D. R., Pasch, T., & Schaub, M. C. (2002) · Anesthesiology · doi:10.1097/00000542-200207000-00003 · Cited by 263
Durgan, D. J., Pulinilkunnil, T., Villegas-Montoya, C., Garvey, M. E., Frangogiannis, N. G., Michael, L. H., Chow, C.-W., Dyck, J. R. B., & Young, M. E. (2010) · Circulation Research · doi:10.1161/circresaha.109.209346 · Cited by 254
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations
Hausenloy, D. J., Baxter, G., Bell, R., Bøtker, H. E., Davidson, S. M., Downey, J., Heusch, G., Kitakaze, M., Lecour, S., Mentzer, R., et al. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0121-4 · Cited by 244 · cited 3×
“Preclinical animal AMI models are not always predictive, and in some cases they poorly represent the clinical setting.(2) Inadequate selection of the animal species could importantly contribute to spurious or incon-”
BackgroundMethodSelf-citationWhite, S. K., Frohlich, G. M., Sado, D. M., Maestrini, V., Fontana, M., Treibel, T. A., Tehrani, S., Flett, A. S., Meier, P., Ariti, C., et al. (2015) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.05.015 · Cited by 238 · cited 1×
“However, in clinical cardioprotection studies in which both MI size and the AAR have been measured using cardiac MRI, mean MI size as a % LV volume has been reported as 15–25%, and the mean infarct size as a % of the AAR has been found to be 39–70%.(10,74,76)”
MethodSelf-citationSix red flags for suspect work
Begley, C. G. (2013) · Nature · doi:10.1038/497433a · Cited by 230
Hausenloy, D. J., Bøtker, H. E., Condorelli, G., Ferdinandy, P., Garcia-Dorado, D., Heusch, G., Lecour, S., van Laake, L. W., Madonna, R., Ruiz-Meana, M., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt004 · Cited by 228
Self-citationWoo, J. S., Kim, W., Ha, S. J., Kim, J. B., Kim, S.-J., Kim, W.-S., Seon, H. J., & Kim, K. S. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301586 · Cited by 223
Schwartz Longacre, L., Kloner, R. A., Arai, A. E., Baines, C. P., Bolli, R., Braunwald, E., Downey, J., Gibbons, R. J., Gottlieb, R. A., Heusch, G., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.032698 · Cited by 216
Self-citationCircadian variations of infarct size in acute myocardial infarction
Suárez-Barrientos, A., López-Romero, P., Vivas, D., Castro-Ferreira, F., Núñez-Gil, I., Franco, E., Ruiz-Mateos, B., García-Rubira, J. C., Fernández-Ortiz, A., Macaya, C., et al. (2011) · Heart · doi:10.1136/hrt.2010.212621 · Cited by 216
Myocardial hibernation: a delicate balance
Heusch, G., Schulz, R., & Rahimtoola, S. H. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01109.2004 · Cited by 200
Self-citationIschemic postconditioning: experimental models and protocol algorithms
Skyschally, A., Caster, P., Iliodromitis, E. K., Schulz, R., Kremastinos, D. T., & Heusch, G. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0040-4 · Cited by 199
Self-citationPizarro, G., Fernández-Friera, L., Fuster, V., Fernández-Jiménez, R., García-Ruiz, J. M., García-Álvarez, A., Mateos, A., Barreiro, M. V., Escalera, N., Rodriguez, M. D., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.014 · Cited by 196
Thielmann, M., Dörge, H., Martin, C., Belosjorow, S., Schwanke, U., van de Sand, A., Konietzka, I., Büchert, A., Krüger, A., Schulz, R., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000014451.75415.36 · Cited by 193
Self-citationHEUSCH, G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.1055 · Cited by 182
Self-citationCoronary Microembolization: the Role of TNF- α in Contractile Dysfunction
Dörge, H., Schulz, R., Belosjorow, S., Post, H., van de Sand, A., Konietzka, I., Frede, S., Hartung, T., Vinten-Johansen, J., Youker, K. A., et al. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1489 · Cited by 180
Self-citationJalowy, A., Schulz, R., Dörge, H., Behrends, M., & Heusch, G. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00441-0 · Cited by 179
Self-citationDepression and cardiac risk: present status and future directions
Frasure-Smith, N., & Lespérance, F. (2010) · Heart · doi:10.1136/hrt.2009.186957 · Cited by 175 · cited 1×
“with IHD and are independently associated with increased cardiovascular morbidity and mortality.(122) In experimental models, depression alters cardioprotective strategies,(123) and researchers usually avoid exposing”
BackgroundMiki, T., Itoh, T., Sunaga, D., & Miura, T. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-67 · Cited by 173
Animal models for the study of human disease
Conn, P. (2013) · Elsevier eBooks · doi:10.1016/c2011-0-05225-0 · Cited by 169
Skyschally, A., Gres, P., Hoffmann, S., Haude, M., Erbel, R., Schulz, R., & Heusch, G. (2006) · Circulation Research · doi:10.1161/01.res.0000255031.15793.86 · Cited by 161
Self-citationPerfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation
Dörge, H., Neumann, T., Behrends, M., Skyschally, A., Schulz, R., Kasper, C., Erbel, R., & Heusch, G. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.6.h2587 · Cited by 161 · cited 1×
“Since coronary microembolization induces permanent coronary microvascular obstruction, patchy MI with a subsequent inflammatory reaction ensues.(47) Infiltration of leucocytes goes along with increased expression of tumour necrosis factor alpha (TNFa),(48) and a signal transduction of nitric oxide, sphingosine, and re…”
BackgroundSelf-citationSurgical animal models of heart failure related to coronary heart disease
KLOCKE, R., TIAN, W., KUHLMANN, M., & NIKOL, S. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.11.026 · Cited by 160 · cited 1×
“Left anterior descending coronary artery ligation following left thoracotomy is by far the most commonly used technique, although the model can be time-consuming and the recovery model is associated with a high mortality rate, varying from 20 to 50% according to the species.(41)”
Ibanez, B., Prat-González, S., Speidl, W. S., Vilahur, G., Pinero, A., Cimmino, G., García, M. J., Fuster, V., Sanz, J., & Badimon, J. J. (2007) · Circulation · doi:10.1161/circulationaha.106.679639 · Cited by 159 · cited 1×
“However, a more recent study in pigs was able to take advantage of delayedenhancement cardiac MRI in order to accurately quantify the extent of myocardial necrosis in vivo, and used a clinically relevant study design with metoprolol administered after the onset of ischaemia but before the onset of reperfusion.(129,130…”
MethodCanton, M., Skyschally, A., Menabò, R., Boengler, K., Gres, P., Schulz, R., Haude, M., Erbel, R., Di Lisa, F., & Heusch, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi751 · Cited by 149 · cited 1×
“Infiltration of leucocytes goes along with increased expression of tumour necrosis factor alpha (TNFa),(48) and a signal transduction of nitric oxide, sphingosine, and reactive oxygen species formation with subsequent oxidativemodification of the contractilemachinery induces contractile dysfunction.(49,50) On the othe…”
BackgroundSelf-citationReiter, R., Swingen, C., Moore, L., Henry, T. D., & Traverse, J. H. (2012) · Circulation Research · doi:10.1161/circresaha.111.254284 · Cited by 138
Gender Differences in Cardiac Ischemic Injury and Protection—Experimental Aspects
Ostadal, B., Netuka, I., Malý, J., Bešík, J., & Ostadalova, I. (2009) · Experimental Biology and Medicine · doi:10.3181/0812-mr-362 · Cited by 135 · cited 1×
“Cardioprotective strategies such as ischaemic pre- and postconditioning also appear tobe influenced by the gender of the animal, and menopause may affect resistance towards I/R injury during aging in females.(98) Similarly, while pre- and postconditioning attenuate I/R injury in young animal hearts, most studies sugge…”
BackgroundThe in-situ pig heart with regional ischemia/reperfusion — Ready for translation
Heusch, G., Skyschally, A., & Schulz, R. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.02.016 · Cited by 134
Self-citationNitroglycerin and Delayed Preconditioning in Humans
Heusch, G. (2001) · Circulation · doi:10.1161/01.cir.103.24.2876 · Cited by 133 · cited 1×
“On the other hand, the enhanced expression of TNFa following coronary microembolization can protect from subsequent MI,(51) and this may partially explain the protection observed clinically with pre-infarction angina.(52,53)”
BackgroundSelf-citationFerdinandy, P., Szilvássy, Z., Horváth, L. I., et al. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0557 · Cited by 129
Self-citationMyocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion
GARCIA-DORADO, D., Théroux, P., Elízaga, J., Galiñanes, M., Solares, J., Riesgo, M. J., GOMEZ, M. J., GARCIA-DORADO, A., & AVILES, F. F. (1987) · Cardiovascular Research · doi:10.1093/cvr/21.7.537 · Cited by 126
Self-citationCardiac preconditioning for ischaemia: lost in translation
Ludman, A. J., Yellon, D. M., & Hausenloy, D. J. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.003855 · Cited by 126 · cited 3×
“small and large animal cardiac MRI (MRI) allow one to serially assess the cardioprotective efficacy of the novel therapy on MI size, cardiac function, and post-MI remodelling over time.(40) Preclinical assessment for cardioprotection 403”
BackgroundInfluentialSelf-citationExtrapolating from animals to humans
Ioannidis, J. P. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004631 · Cited by 124 · cited 1×
“Previous studies have shown that when such guidelines are not adhered to, the odds of obtaining significant effects in animal studies can be approximately three-fold higher.(20) It has been proposed that animal trials should be pre-registered, similar to clinical trials.”
BackgroundAtherosclerosis and thrombosis: insights from large animal models
Vilahur, G., Padro, T., & Badimon, L. (2011) · BioMed Research International · doi:10.1155/2011/907575 · Cited by 118 · cited 1×
“Also, and unlike other animals, pigs may develop coronary restenosis after gradual occlusion.(94) Primates are notoriously resistant to MI and develop only 17% infarct size of the AAR after 90 min coronary occlusion.”
BackgroundThe ERICCA Trial Investigators, Hausenloy, D. J., Candilio, L., Laing, C. M., Kunst, G., Pepper, J., Kolvekar, S. K., Evans, R., Robertson, S., Knight, R., et al. (2011) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0397-x · Cited by 115
Self-citationCour, M., Loufouat, J., Paillard, M., Augeul, L., Goudable, J., Ovize, M., & Argaud, L. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq112 · Cited by 110 · cited 1×
“These animal CA models have been used to investigate a number of cardioprotective therapies, including inhaled anaesthetics 58 and cyclosporine A.(59,60)”
BackgroundSelf-citationKhaliulin, I., Clarke, S. J., Lin, H., Parker, J. E., Suleiman, M. S., & Halestrap, A. P. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.130369 · Cited by 99 · cited 1×
“Some efforts have been made to characterize or even therapeutically translate the mechanisms by which these environmental aspects may influence the damage induced by I/R injury and the therapeutic effects of cardioprotection.(125,126) The development of systems biology approaches may”
BackgroundFerrera, R., Benhabbouche, S., Bopassa, J. C., Li, B., & Ovize, M. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-009-6176-5 · Cited by 96
Self-citationIn Vitro Studies of Human Hearts
Hill, A. J., Laske, T. G., Coles, J. A., Sigg, D. C., Skadsberg, N. D., Vincent, S. A., Soule, C. L., Gallagher, W. J., & Iaizzo, P. A. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.06.080 · Cited by 95 · cited 1×
“The Langendorff-perfused heart was first used at the end of the 19th century, and comprises mounting the isolated heart on the aortic cannula of a Langendorff perfusion apparatus and retrogradely perfusing the heart at a constant flow or constant pressure, using blood or oxygenated buffer (typically Krebs–Henseleit so…”
MethodBarnabei, M. S., Palpant, N. J., & Metzger, J. M. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00071.2010 · Cited by 88
In silico modelling of physiologic systems
Colquitt, R. B., Colquhoun, D. A., & Thiele, R. H. (2011) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2011.08.006 · Cited by 88 · cited 1×
“4 Computational models In silico (‘in silicon’) systems, in which mathematical models of a physiological or pharmacological system are developed and tested on a computer, are a hybrid of in vivo/ex vivo and in vitro techniques.(64) Like in vivo techniques, in silico experiments are designed to mimic the behaviour of o…”
BackgroundLefer, D. J., & Bolli, R. (2011) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248411414155 · Cited by 86 · cited 1×
“consortium is to test promising therapies in three species (in vivo acute I/R injury rodent, rabbit, and porcine models) across three centres.(23)”
BackgroundPrzyklenk, K. (2011) · Drugs & Aging · doi:10.2165/11587190-000000000-00000 · Cited by 86
Organ reperfusion and preservation
Jamieson, R. W. (2007) · Frontiers in bioscience · doi:10.2741/2672 · Cited by 85 · cited 1×
“Acute myocardial I/R injury sustained during cardiac transplantation can contribute to graft vasculopathy and failure.(61) Therefore, novel cardioprotective strategies are required to protect the transplanted heart from the detrimental effects of acute I/R injury in order to preserve graft function.”
BackgroundIschemic preconditioning and preinfarction angina in the clinical arena
Rezkalla, S. H., & Kloner, R. A. (2004) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0047 · Cited by 83 · cited 1×
“On the other hand, the enhanced expression of TNFa following coronary microembolization can protect from subsequent MI,(51) and this may partially explain the protection observed clinically with pre-infarction angina.(52,53)”
BackgroundMeasurement of myocardial infarct size in preclinical studies
Csonka, C., Kupai, K., Kocsis, G. F., Novák, G., Fekete, V., Bencsik, P., Csont, T., & Ferdinándy, P. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.02.014 · Cited by 76
Natarajan, R., Salloum, F. N., Fisher, B. J., Ownby, E. D., Kukreja, R. C., & Fowler, A. A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00291.2007 · Cited by 75
Roubille, F., Lairez, O., Mewton, N., Rioufol, G., Ranc, S., Sanchez, I., Cung, T. T., Elbaz, M., Piot, C. A., & Ovize, M. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0275-3 · Cited by 75 · cited 1×
“Platelet inhibition by clopidogrel, prasugrel, or ticagrelor has been shown to reduce infarct size in animal models and some data exist to also prove clinical efficacy.(111) The mechanisms involved have been suggested to involve nitric oxide (clopidogrel) or adenosine (ticagrelor).”
BackgroundSelf-citationMeybohm, P., Gruenewald, M., Albrecht, M., Zacharowski, K. D., Lucius, R., Zitta, K., Koch, A. H., Tran, N., Scholz, J., & Bein, B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007588 · Cited by 74
Kottenberg, E., Thielmann, M., Kleinbongard, P., Frey, U. H., Heine, T., Jakob, H. G., Heusch, G., & Peters, J. (2014) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12278 · Cited by 73 · cited 1×
“For example, the beneficial effects of angiotensin-converting enzyme (ACE) inhibitors and/or angiotensin receptor (AT)1-receptorantagonists areattenuatedwhencyclooxygenase (COX) inhibitors are simultaneously applied,(108) and the beneficial effects of metformin in diabetic patients is lost when co-administered with th…”
BackgroundSelf-citationOtsuka, T., Kawai, M., Togo, Y., Goda, R., Kawase, T., Matsuo, H., Iwamoto, A., Nagasawa, M., Furuse, M., & Yasuo, S. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.10.013 · Cited by 72
Beyersdorf, F. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp110 · Cited by 71 · cited 1×
“Following a sustained episode of lethal I/R, the major determinants of MI size are the AAR of infarction, the duration of ischaemia, and the presence of collaterals.(62) Therefore, providing the index ischaemic time is fixed, significant collateralization has been excluded or accounted for, and MI size should be expre…”
BackgroundBaxter, G. F., Hale, S. L., Miki, T., Kloner, R. A., Cohen, M. V., Downey, J. M., & Yellon, D. M. (2000) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007850527878 · Cited by 66 · cited 1×
“The results of this rigorous trial were negative.(22) However, the disappointment of negative results must be weighed against the benefit of being abletorefocuseffortsondrugs,whicharemore likely tobeclinically translatable.”
BackgroundSelf-citationRusscher, M., Koch, B. C. P., Nagtegaal, J. E., van Ittersum, F. J., Jong, P. C. M. P.-D., Hagen, E. C., van Dorp, W. T., Gabreëls, B. A. T. F., Wildbergh, T. X., van der Westerlaken, M. M. L., et al. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12093 · Cited by 63 · cited 1×
“Co-morbidities such as diabetes can further disturb circadian rhythms as has been demonstrated in patients.(112,119)”
BackgroundAnthrax Vaccine–Induced Antibodies Provide Cross-Species Prediction of Survival to Aerosol Challenge
Fay, M. P., Follmann, D. A., Lynn, F., Schiffer, J. M., Stark, G. V., Kohberger, R. C., Quinn, C. P., & Nuzum, E. O. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004073 · Cited by 58
Schuster, A., Grünwald, I., Chiribiri, A., Southworth, R., Ishida, M., Hay, G., Neumann, N., Morton, G., Perera, D., Schaeffter, T., et al. (2010) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-12-53 · Cited by 56 · cited 1×
“This model is most often used for perfusing hearts from small animals such as mice, rats, rabbits, and guinea pigs, but it can also be used for larger animal hearts from pig and even human hearts.(37,38) The ischaemic insult is induced regionally by coronary ligation (thereby mimicking a clinical AMI) or globally via…”
MethodInnate protection of baboon myocardium: effects of coronary artery occlusion and reperfusion
Shen, Y. T., Fallon, J. T., Iwase, M., & Vatner, S. F. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.5.h1812 · Cited by 40 · cited 1×
“Primates are notoriously resistant to MI and develop only 17% infarct size of the AAR after 90 min coronary occlusion.(95) Finally, it is important to take into account that some of the most powerful cardioprotective strategies like pre- and postconditioning have been proved to be more dependent on age, co-morbidities…”
BackgroundKnapp, J., Bergmann, G., Bruckner, T., Russ, N., Böttiger, B. W., & Popp, E. (2013) · Resuscitation · doi:10.1016/j.resuscitation.2013.04.012 · Cited by 40
Ferrero, J. M., Trénor, B., & Romero, L. (2014) · EP Europace · doi:10.1093/europace/eut405 · Cited by 35 · cited 2×
“In silico (‘in silicon’) systems, in which mathematical models of a physiological or pharmacological system are developed and tested on a computer, are a hybrid of in vivo/ex vivo and in vitro techniques.64 Like in vivo techniques, in silico experiments are designed to mimic the behaviour of organisms in their entiret…”
BackgroundCurrent preservation technology and future prospects of thoracic organs. Part 2: heart
Jacobs, S., Rega, F., & Meyns, B. P. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328337343f · Cited by 34
Simulated urban carbon monoxide air pollution exacerbates rat heart ischemia-reperfusion injury
Meyer, G., André, L., Tanguy, S., Boissière, J., Farah, C., Lopez‐Lauri, F., Gayrard, S., Richard, S., Boucher, F. R., Cazorla, O., et al. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01194.2009 · Cited by 33 · cited 1×
“Some efforts have been made to characterize or even therapeutically translate the mechanisms by which these environmental aspects may influence the damage induced by I/R injury and the therapeutic effects of cardioprotection.(125,126) The development of systems biology approaches may”
BackgroundStrijdom, H., Genade, S., & Lochner, A. (2004) · Cardiovascular Drugs and Therapy · doi:10.1023/b:card.0000029027.50796.84 · Cited by 31
Meybohm, P., Gruenewald, M., Albrecht, M., Müller, C., Zitta, K., Fösel, N., Maracke, M., Tacke, S., Schrezenmeir, J., Scholz, J., et al. (2011) · Critical Care · doi:10.1186/cc10496 · Cited by 30
Circadian Rhythms in Cell Maturation
du Pré, B. C., van Veen, T. A. B., Young, M. E., Vos, M. A., Doevendans, P. A., & Laake, L. W. V. (2014) · Physiology · doi:10.1152/physiol.00036.2013 · Cited by 29
Zhuo, C., Wang, Y., Wang, X., Wang, Y., & Chen, Y. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0589-0 · Cited by 28
Lim, N. R., Thomas, C. J., Silva, L. S., Yeap, Y. Y. C., Yap, S., Bell, J. R., Delbridge, L. M. D., Bogoyevitch, M. A., Woodman, O. L., Williams, S. J., et al. (2013) · Biochemical Journal · doi:10.1042/bj20121538 · Cited by 26
Wayman, N. S., McDonald, M. C., Chatterjee, P. K., & Thiemermann, C. (2003) · Humana Press eBooks · doi:10.1385/1-59259-374-7:199 · Cited by 25 · cited 1×
“In rodent models of AMI, 30–40 min of either regional or global myocardial ischaemia is sufficient to induce an MI size of 50% of the AAR, whereas in porcine and primate MI models, which are more representative of the human physiology in terms of ischaemic time, 50–90 min of myocardial ischaemia is required to achieve…”
MethodLefer, D. J., Jones, S. P., Steenbergen, C., Kukreja, R. C., Guo, Y., Tang, X., Li, Q., Ockaili, R. A., Salloum, F. N., Kong, M., et al. (2014) · The FASEB Journal · doi:10.1096/fasebj.28.1_supplement.lb645 · Cited by 23
Povlsen, J. A., Løfgren, B., Dalgas, C., Jespersen, N. R., Johnsen, J., & Bøtker, H. E. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.11.035 · Cited by 21
Animal Models of Cardiopulmonary Bypass: Development, Applications, and Impact
Jungwirth, B., & de Lange, F. (2010) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253210370491 · Cited by 20 · cited 1×
“Therefore, in order to simulate the clinical setting of cardiac bypass surgery, a specific I/R injury model of CPB may be better suited to test novel cardioprotective therapies.(54) In this regard, there are rat models of CPB which are well-established and have the following advantages when compared with larger animal…”
BackgroundJia, E., Xu, Z.-X., Cai, H., Guo, C., Li, L., Zhu, T., Wang, L.-S., Cao, K., Ma, W., & Yang, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032478 · Cited by 20
Physiological, Hematological, and Clinical Chemistry Parameters, Including Conversion Factors
Østergaard, G., Hansen, H. N., & Ottesen, J. L. (2010) · CRC Press eBooks · doi:10.1201/b10416-25 · Cited by 19
Is protection by inhalation agents volatile? Controversies in cardioprotection
Zaugg, M. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/aem276 · Cited by 18 · cited 1×
“1 Choice of anaesthetic Although volatile anaesthetics arecurrently the preferreddrug of choice to anaesthetize animals in preclinical experiments, their use in cardioprotective studies has been limited, due to their inherent cardioprotective properties.(19,67,68) Ex vivo, the use of sodium pentobarbitone remains the…”
BackgroundGörbe, A., Varga, Z. V., Pálóczi, J., Rungarunlert, S., Klincumhom, N., Pirity, M. K., Madonna, R., Eschenhagen, T., Dinnyés, A., Csont, T., et al. (2013) · Molecular Biotechnology · doi:10.1007/s12033-013-9704-2 · Cited by 15
Self-citationYuan, D., Huang, J., Yuan, X., Zhao, J., & Jiang, W. (2013) · Biomedical Reports · doi:10.3892/br.2013.124 · Cited by 15
Ammirati, E., Maseri, A., & Cannistraci, C. V. (2013) · Circulation Research · doi:10.1161/circresaha.113.301908 · Cited by 13 · cited 1×
“MI size and LV function after reperfused STEMI in humans are also correlated with the time-of-day onset of symptoms even when corrected for confounders,(115,116) although this notion is not unequivocal.(117) Importantly, the amplitude of circadian variation but also the capacity of animals to adapt to externally induc…”
BackgroundHausenloy, D. J., & Yellon, D. M. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr382 · Cited by 12
Self-citationCavalheiro, R. A., Marin, R. M., Rocco, S. A., Cerqueira, F. M., da Silva, C. C. C., Rittner, R., Kowaltowski, A. J., Vercesi, A. E., Franchini, K. G., & Castilho, R. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010666 · Cited by 12
Ferraro, S., Biganzoli, E. M., Marano, G., Santagostino, M., Boracchi, P., Panteghini, M., & Bongo, A. S. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.03.026 · Cited by 12
Somers, S., Lacerda, L., Opie, L. H., & Lecour, S. (2011) · Physiological Research · doi:10.33549/physiolres.932129 · Cited by 11 · cited 3×
“Hence, six cycles of ischaemia and reperfusion as an ischaemic postconditioning cardioprotective strategy in the isolated mouse heart model subjected to ischaemia– reperfusion reduced the infarct size in C57BL/6 pure mice, but failed to protect in C57BL/6 floxed signal transducer and activator of transcription (STAT-3…”
MethodInfluentialSelf-citationModels for the Study of Atherosclerosis and Thrombosis
Badimón, L., Casaní, L., & Vilahur, G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00010-5 · Cited by 7 · cited 2×
“Small-sized animals, typically mice and rats, and to a lesser extent guinea pigs and rabbits, are extensively used in cardioprotection studies, mainly due to their lower cost, shorter gestation time, easier handling, and well-characterized native or manipulated genetic profile.(84) This practice is facilitated by the…”
Background
Cited by
Myocardial ischaemia–reperfusion injury and cardioprotection in perspective
Heusch, G. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0403-y · Cited by 1,234
Self-citationOng, S.-B., Hernández-Reséndiz, S., Crespo-Avilan, G. E., Mukhametshina, R. T., Kwek, X.-Y., Cabrera-Fuentes, H. A., & Hausenloy, D. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.001 · Cited by 918
Self-citationKalogeris, T., Baines, C. P., Krenz, M., & Korthuis, R. J. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c160006 · Cited by 718
Heusch, G., & Gersh, B. J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw224 · Cited by 676
Self-citationIschaemic conditioning and reperfusion injury
Hausenloy, D. J., & Yellon, D. M. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.5 · Cited by 579
Self-citation
Metadata
- Authors
- Lecour, S., Botker, H. E., Condorelli, G., Davidson, S. M., Garcia-Dorado, D., Engel, F. B., Ferdinandy, P., Heusch, G., Madonna, R., Ovize, M., Ruiz-Meana, M., Schulz, R., Sluijter, J. P. G., Van Laake, L. W., Yellon, D. M., & Hausenloy, D. J.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-10-24
- Volume
- 104
- Issue
- 3
- Pages
- 399-411
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2137442910
- Cited by
- 164
- References
- 120
- FWCI
- 14.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.